Patients with cancer receiving chemotherapeutics may develop diarrhea, which can be highly distressing. In a recent journal article, oncologist Marcus Hentrich, MD, and gastroenterologist Volker Penndorf, […]

A new study confirmed an elevated risk for myelodysplastic syndrome or acute myeloid leukemia (MDS/AML) after poly(ADP-ribose) polymerase (PARP) inhibitor therapy in women with ovarian cancer […]

Adding low-dose radiation to the current standard first-line treatment, durvalumab plus etoposide-platinum chemotherapy, appears to improve survival outcomes in patients with extensive-stage small cell lung cancer […]

TOPLINE: Detecting sarcopenia at baseline alongside markers of malnutrition could guide decision-making regarding the need for feeding tube placement in patients with oropharyngeal squamous cell carcinoma […]

TOPLINE: Detecting sarcopenia at baseline alongside markers of malnutrition could guide decision-making regarding the need for feeding tube placement in patients with oropharyngeal squamous cell carcinoma […]

(Reuters) – Merck said on Thursday a combination of two of its cancer drugs failed to meet the main goals of a late-stage study evaluating it […]

While it is increasingly apparent that clonal hematopoiesis of indeterminate potential (CHIP) is associated with conditions that can dramatically affect an individual’s risk for both malignant […]

A new way of using artificial intelligence (AI) can predict breast cancer 5 years in advance with impressive accuracy — and unlike previous AI models, we […]

An advisory panel at the US Food and Drug Administration (FDA) lent support to bids that allow for earlier use of chimeric antigen receptor (CAR-T) therapies […]